Recent Updates
Recently added Catalysts

ventriculo-peritoneal shunt

Phase 2

Idiopathic Normal Pressure Hydrocephalus | Unknown | Other |Johnson & Johnson|Trials Updated: Feb 9, 2009

ventriculo-peritoneal shunt development status

Highest phase Phase 2
Registered trials 1 across 1 sponsor since Sep 2005

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

UNCONTROLLED
Total Trials1
Total Enrollment110

FDA Designations

No designations recorded

ventriculo-peritoneal shunt clinical trials

ventriculo-peritoneal shunt · 1 trial · 1 indication

Phase 2 1
NCT00221091Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure HydrocephalusIdiopathic Normal Pressure Hydrocephalus
COMPLETED110 Analytics
PHASE2COMPLETED
Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus
Idiopathic Normal Pressure Hydrocephalus
NCT00221091110
Unlock trial analytics

Study Endpoints

Primary Endpoints

modified Rankin scale

Secondary Endpoints

cognitive function, NPH grading scale
Unlock Study Endpoints

Study Design & Arms

AllocationNON_RANDOMIZED
MaskingNONE
ModelSINGLE_GROUP
PurposeTREATMENT

Interventions

NameTypeDescription
ventriculo-peritoneal shuntPROCEDURE -
Unlock Study Design Details

Eligibility Criteria

Age Range60 Years to 85 Years
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: Patients who had at least one more points of the triad (gait disturbance, cognitive impairment, and urinary incontinence) in Japan NPH grading scale revised, and had disproportionate ventriculomegaly (Evans index \>0.3) with closing of the CSF space at high convexity on MRI. The...

Countries:Japan
Unlock Eligibility Criteria

Explore more on BiopharmaWatch

Johnson & Johnson (JNJ)Pipeline, catalysts, financials, insiders and newsBiotech disease mapWho is developing what in each indication, and how crowded it isFDA calendarUpcoming PDUFA dates, AdComs and approval oddsPDUFA calendarEvery scheduled FDA decision date, month by monthHistorical FDA calendarPast decisions and how the stock moved on eachCatalyst SyncUpcoming readouts and decisions, screened by runway and phaseBiotech stock screenerFilter by clinical phase, cash runway and market capDrugs A to ZEvery drug page starting with VCompanies A to ZEvery biotech and pharma company we track